Dermatology News and Research

Latest Dermatology News and Research

Dynatronics net sales decrease 2.9% in fourth quarter 2014

Dynatronics Corporation today announced results for its fiscal fourth quarter and year ended June 30, 2014.

29 Sep 2014

Research findings open up new avenues for development of chronic itch treatments

Areas of the brain that respond to reward and pleasure are linked to the ability of a drug known as butorphanol to relieve itch, according to new research led by Gil Yosipovitch, MD, Professor and Chairman of the Department of Dermatology at Temple University School of Medicine, and Director of the Temple Itch Center.

25 Sep 2014

Photoelectric therapy for non-melanoma skin cancer developed by Xstrahl

With a presence in over 500 clinics around the world, Xstrahl have drawn upon their vast clinical expertise to develop a revolutionary system that has been specifically designed for the treatment superficial skin cancers and skin conditions.

From Xstrahl 18 Sep 2014

Soldiers deployed to sunny climates face increased risk of skin cancer

Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer.

17 Sep 2014

Multi-purpose swabs available from Qosina

Qosina offers a wide selection of high quality and economical single-use swabs, in addition to its extensive line of single-use components. These products can be used for countless applications in the medical, biological, chemical, pharmaceutical, optical, electronic, industrial, cosmetic, and dermatological industries. Available in a variety of materials, shapes, and sizes, these swabs are ideal for general cleaning, applying or removing product, sample retrieval, and other precision applications.

12 Sep 2014

University of Michigan Health System becomes one of best places for young doctors to train

Doctors nationwide rate the University of Michigan Health System as one of the best places for young doctors to train in their chosen field, across 20 medical specialties, according to a new ranking released today.

11 Sep 2014

Researchers discover new details of how autoantibodies destroy healthy cells in skin

University at Buffalo researchers and colleagues studying a rare, blistering disease have discovered new details of how autoantibodies destroy healthy cells in skin.

11 Sep 2014

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules.

11 Sep 2014

Morning hypertension unmasked as risk factor for cardiovascular events

Patients on antihypertensive medication who have high blood pressure in the morning, as measured with home monitoring kits, are at increased risk of cardiovascular events, even if their clinic measurement is acceptable, researchers have found.

8 Sep 2014

Genetic mutation caused by ultraviolet light is likely driving force behind human skin cancers

A genetic mutation caused by ultraviolet light is likely the driving force behind millions of human skin cancers, according to researchers at the Stanford University School of Medicine.

8 Sep 2014

Intensive glycaemic control shows ischaemic heart disease benefit

Intensive glucose lowering may significantly reduce the risk of ischaemic heart disease in at-risk middle-aged people with Type 2 diabetes, a post-hoc analysis of the ACCORD trial suggests.

5 Sep 2014

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2

4 Sep 2014

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Since the introduction of the combination anti-retroviral therapy (cART) in the mid-90s, the life expectancy of HIV patients has significantly improved. As a result, long-term complications are becoming more relevant: almost every second HIV patient is affected by neurocognitive disorders, which can lead to dementia.

4 Sep 2014

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.

2 Sep 2014

Dermatology News and Research

Latest Dermatology News and Research

Dynatronics net sales decrease 2.9% in fourth quarter 2014

Research findings open up new avenues for development of chronic itch treatments

Photoelectric therapy for non-melanoma skin cancer developed by Xstrahl

Soldiers deployed to sunny climates face increased risk of skin cancer

Multi-purpose swabs available from Qosina

University of Michigan Health System becomes one of best places for young doctors to train

Researchers discover new details of how autoantibodies destroy healthy cells in skin

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

Morning hypertension unmasked as risk factor for cardiovascular events

Genetic mutation caused by ultraviolet light is likely driving force behind human skin cancers

Intensive glycaemic control shows ischaemic heart disease benefit

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

Findings may help develop biomarkers to identify HIV patients at risk of dementia

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

Blood pressure self-management suitable for high-risk patients

Researchers find method to expand blood stem cells used to treat cancer patients

InnoPharma receives FDA approval for generic DACOGEN

Risk-based treatment approach should be considered for patients with hypertension

Lifestyle intervention shows kidney benefits in diabetic patients

Report on Co-development Terms & Agreements in Pharma, Biotech and Diagnostics

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Dermatology News and Research

Latest Dermatology News and Research

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in